Delivery Order SPE2DX19D5041-SPE2DX23FFBTC
Award Date 5/30/23
Potential Completion Date 5/31/23
Potential Value $300
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 17, 2026, for $19,246.77 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for supply of JAKAFI 10 mg tablets (60-count units). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group Inc. is a woman-owned small business. Place of...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on April 17, 2026, for JAKAFI 10 mg tablets (60-count), with a ceiling value of $75,979.68 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is the Defense Logistics Agency's single-award indefinite delivery contract for pharmaceutical and medical consumable supply to Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical is the sole...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 25, 2026, for $12,663.27, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) parent contract for supply of JAKAFI 10 mg tablets (60-count units). PPV-G GEN V is a Defense Logistics Agency initiative authorizing firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on May 20, 2026, for JAKAFI 10 mg tablets (60 count) with a ceiling value of $25,326.56, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency single-award indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables supporting Department of Defense military healthcare facilities...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical pharmaceutical prime vendor contract to provide pharmaceutical items and medical supplies. The $4,812.26 order is for 4562852692 PHARMACEUTICAL PV DIV - FSB and requires completion by November 15, 2023. As a woman-owned small business, DMS Pharmaceutical Group will supply products from its facilities in Park Ridge, Illinois to Defense Logistics Agency...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on April 23, 2026, for JAKAFI 10 mg tablets (60-count) with a ceiling value of $12,663.27, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a single-award indefinite delivery contract under which DMS Pharmaceutical serves as the sole regional prime vendor for pharmaceutical and medical consumable supply to Department of Defense military healthcare facilities...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on April 20, 2026, with a ceiling value of $12,703.23 for JAKAFI 20MG tablets (60 count), under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is DLA's single-award indefinite delivery contract for branded and generic prescription drugs, biologics, over-the-counter medications, vaccines, and medical consumables supporting Department of Defense military healthcare...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on April 3, 2026, for JAKAFI 10 mg tablets (60 count) with a ceiling value of $12,663.27 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency single-award indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products, biologics, and medical consumables supporting Department of Defense military...
- The Defense Logistics Agency issued a $75,979.68 delivery order to DMS Pharmaceutical Group Inc. on May 11, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for JAKAFI 10 mg tablets (60-count units), with ultimate completion on May 12, 2026. PPV-G GEN V is a Defense Logistics Agency single-award indefinite delivery contract with a $499.999 billion ceiling running through December 31, 2036, under which DMS Pharmaceutical serves as the sole regional prime...
- The Defense Logistics Agency issued a $50,883.68 delivery order to DMS Pharmaceutical Group Inc. on February 6, 2026, for JAKAFI 5 mg tablets (60-count units) under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a DLA-administered indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense...